-
1دورية أكاديمية
المؤلفون: Hao T; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China., Li Y; Clinicopathological Diagnosis & Research Center, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, People's Republic of China.; Key Laboratory of Tumor Molecular Pathology of Guangxi Higher Education Institutes, Baise, People's Republic of China., Liu P; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Wang X; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China., Xu K; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Lei W; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Li Y; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China., Zhang R; State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, Guangxi University, Nanning, People's Republic of China., Li X; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Zhao X; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China., Xu K; Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, People's Republic of China., Lu X; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Bi Y; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China., Song H; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing People's Republic of China.; Beijing Institute of Infectious Diseases, Beijing, People's Republic of China., Wu G; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Zhu B; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China.; Department of Pathogenic Biology, School of Basic Medical Sciences, Southwest Medical University, Luzhou, People's Republic of China., Gao GF; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.; Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, People's Republic of China.
المصدر: PLoS pathogens [PLoS Pathog] 2024 Sep 20; Vol. 20 (9), pp. e1012508. Date of Electronic Publication: 2024 Sep 20 (Print Publication: 2024).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
مواضيع طبية MeSH: SARS-CoV-2*/immunology , COVID-19*/prevention & control , COVID-19*/immunology , mRNA Vaccines*/immunology , Spike Glycoprotein, Coronavirus*/immunology , Spike Glycoprotein, Coronavirus*/genetics , Hemagglutinin Glycoproteins, Influenza Virus*/immunology , Hemagglutinin Glycoproteins, Influenza Virus*/genetics , COVID-19 Vaccines*/immunology, Animals ; Mice ; Humans ; Influenza Vaccines/immunology ; Antibodies, Viral/immunology ; Mice, Inbred BALB C ; Female ; Influenza A Virus, H1N1 Subtype/immunology ; Orthomyxoviridae Infections/prevention & control ; Orthomyxoviridae Infections/immunology ; Vaccines, Synthetic/immunology ; Influenza, Human/prevention & control ; Influenza, Human/immunology ; Antibodies, Neutralizing/immunology
SCR Organism: SARS-CoV-2 variants
-
2دورية أكاديمية
المؤلفون: Chandra S; School of Pharmacy & Medical Sciences, Gold Coast campus, Griffith University, Brisbane, QLD-4222, Australia.; Menzies Health Institute Queensland (MHIQ), Gold Coast Campus, Griffith University, Brisbane, QLD-4215, Australia., Wilson JC; School of Pharmacy & Medical Sciences, Gold Coast campus, Griffith University, Brisbane, QLD-4222, Australia.; Menzies Health Institute Queensland (MHIQ), Gold Coast Campus, Griffith University, Brisbane, QLD-4215, Australia., Good D; School of Allied Health, Australian Catholic University, Brisbane, QLD-4014, Australia., Wei MQ; School of Pharmacy & Medical Sciences, Gold Coast campus, Griffith University, Brisbane, QLD-4222, Australia.; Menzies Health Institute Queensland (MHIQ), Gold Coast Campus, Griffith University, Brisbane, QLD-4215, Australia.
المصدر: Oncology research [Oncol Res] 2024 Sep 18; Vol. 32 (10), pp. 1543-1564. Date of Electronic Publication: 2024 Sep 18 (Print Publication: 2024).
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Tech Science Press Country of Publication: United States NLM ID: 9208097 Publication Model: eCollection Cited Medium: Internet ISSN: 1555-3906 (Electronic) Linking ISSN: 09650407 NLM ISO Abbreviation: Oncol Res Subsets: MEDLINE
مواضيع طبية MeSH: mRNA Vaccines* , Cancer Vaccines*/immunology , Cancer Vaccines*/therapeutic use , Neoplasms*/immunology , Neoplasms*/therapy , Neoplasms*/prevention & control , Vaccine Development*, Humans ; COVID-19 Vaccines/immunology ; COVID-19/prevention & control ; COVID-19/immunology ; Vaccines, Synthetic/immunology ; RNA, Messenger/genetics ; Antigens, Neoplasm/immunology ; Antigens, Neoplasm/genetics ; SARS-CoV-2/immunology ; SARS-CoV-2/genetics
-
3دورية أكاديمية
المؤلفون: Rzymski P; Department of Environmental Medicine, Poznan University of Medical Sciences, Poznań, Poland.; Universal Scientific Education and Research Network (USERN)., Jibril AT; Universal Scientific Education and Research Network (USERN).; Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran., Rahmah L; Universal Scientific Education and Research Network (USERN).; Faculty of Medicine, Universitas Muhammadiyah Surabaya, Surabaya, Indonesia.; Department of Digital Health, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Abarikwu SO; Universal Scientific Education and Research Network (USERN).; Department of Biochemistry, University of Port Harcourt, Choba, PMB, Port Harcourt, Rivers State, Nigeria., Hashem F; Universal Scientific Education and Research Network (USERN).; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Lawati AA; Universal Scientific Education and Research Network (USERN).; Sultan Qaboos University Hospital, Al Khoud, Muscat, Oman., Morrison FMM; Universal Scientific Education and Research Network (USERN).; Akkon University of Human Sciences, Berlin, Germany., Marquez LP; Universal Scientific Education and Research Network (USERN).; University of the Philippines Diliman, Quezon City, Philippines., Mohamed K; Universal Scientific Education and Research Network (USERN).; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Khan A; Universal Scientific Education and Research Network (USERN).; Department of Pharmacy, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.; Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan., Mushtaq S; Universal Scientific Education and Research Network (USERN).; Department of Pharmacy, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China., Minakova K; Universal Scientific Education and Research Network (USERN).; Micro- and Nanoelectronics Department, National Technical University 'Kharkiv Polytechnic Institute', Kharkiv, Ukraine., Poniedziałek B; Department of Environmental Medicine, Poznan University of Medical Sciences, Poznań, Poland., Zarębska-Michaluk D; Department of Infectious Diseases, Jan Kochanowski University, Kielce, Poland., Flisiak R; Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, Poland.
المصدر: Journal of medical virology [J Med Virol] 2024 Sep; Vol. 96 (9), pp. e29900.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071 (Electronic) Linking ISSN: 01466615 NLM ISO Abbreviation: J Med Virol Subsets: MEDLINE
مواضيع طبية MeSH: Viral Hepatitis Vaccines*/immunology , Hepatitis C*/prevention & control , Hepatitis C*/immunology , Hepacivirus*/immunology , Hepacivirus*/genetics , Vaccine Development*, Humans ; Antibodies, Neutralizing/immunology ; Vaccines, Subunit/immunology ; Animals ; Vaccines, Inactivated/immunology
-
4دورية أكاديمية
المؤلفون: Cao Y; Department of Global Health, Milken Institute School of Public Health, George Washington University, Washington D.C., USA., Hayashi CTH; Department of Global Health, Milken Institute School of Public Health, George Washington University, Washington D.C., USA., Araujo MDS; Plataforma de Produção e Infecção de Vetores da Malária, Laboratório de Entomologia - FIOCRUZ RO, Rua da Beira 7671, CEP 76812-245 Porto Velho RO, Brazil; Programa de Pós-Graduação em Saúde Pública, Faculdade de Saúde Pública, Universidade Federal de São Paulo, São Paulo 01246-904, SP, Brazil., Tripathi AK; Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Andrade AO; Plataforma de Produção e Infecção de Vetores da Malária, Laboratório de Entomologia - FIOCRUZ RO, Rua da Beira 7671, CEP 76812-245 Porto Velho RO, Brazil; Programa de Pós-Graduação em Saúde Pública, Faculdade de Saúde Pública, Universidade Federal de São Paulo, São Paulo 01246-904, SP, Brazil., Medeiros JF; Plataforma de Produção e Infecção de Vetores da Malária, Laboratório de Entomologia - FIOCRUZ RO, Rua da Beira 7671, CEP 76812-245 Porto Velho RO, Brazil; Programa de Pós-Graduação em Biologia Experimental, Fundação Universidade Federal de Rondônia, Fiocruz Rondônia 76812-245, Brazil., Vinetz J; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; Department of Cellular and Molecular Sciences, Faculty of Sciences, and Alexander von Humboldt Institute of Tropical Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru., Kumar N; Department of Global Health, Milken Institute School of Public Health, George Washington University, Washington D.C., USA. Electronic address: nkumar@gwu.edu.
المصدر: Vaccine [Vaccine] 2024 Aug 30; Vol. 42 (21), pp. 126140. Date of Electronic Publication: 2024 Jul 20.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
مواضيع طبية MeSH: Malaria Vaccines*/immunology , Malaria Vaccines*/administration & dosage , Malaria, Falciparum*/prevention & control , Malaria, Falciparum*/transmission , Malaria, Falciparum*/immunology , Plasmodium falciparum*/immunology , Plasmodium falciparum*/genetics , Plasmodium vivax*/immunology , Plasmodium vivax*/genetics , Malaria, Vivax*/prevention & control , Malaria, Vivax*/transmission , Malaria, Vivax*/immunology , Vaccines, DNA*/immunology , Vaccines, DNA*/administration & dosage , Antibodies, Protozoan*/immunology , Antibodies, Protozoan*/blood, Animals ; Mice ; Female ; Vaccines, Combined/immunology ; Vaccines, Combined/administration & dosage ; Antigens, Protozoan/immunology ; Antigens, Protozoan/genetics ; Protozoan Proteins/immunology ; Protozoan Proteins/genetics ; Mice, Inbred BALB C ; Humans
-
5دورية أكاديمية
المؤلفون: Dallan B; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy., Proietto D; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy., De Laurentis M; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy., Gallerani E; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy., Martino M; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy., Ghisellini S; Laboratory of Clinical Pathology, University Hospital St. Anna, Ferrara, Italy., Zurlo A; Department of Medical Sciences, University of Ferrara, Geriatrics Unit, University Hospital of Ferrara, Ferrara, Italy., Volpato S; Department of Medical Sciences, University of Ferrara, Geriatrics Unit, University Hospital of Ferrara, Ferrara, Italy., Govoni B; Department of Medical Sciences, University of Ferrara, Geriatrics Unit, University Hospital of Ferrara, Ferrara, Italy., Borghesi M; Department of Economics and Management, University of Ferrara, Ferrara, Italy., Albanese V; Department of Environmental and Prevention Sciences, University of Ferrara, Ferrara, Italy., Appay V; Université de Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, Bordeaux, France., Bonnini S; Department of Economics and Management, University of Ferrara, Ferrara, Italy., Llewellyn-Lacey S; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK., Pacifico S; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy., Grumiro L; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Brandolini M; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Semprini S; Unit of Microbiology, Greater Romagna Area Hub Laboratory, Cesena, Italy., Sambri V; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.; Unit of Microbiology, Greater Romagna Area Hub Laboratory, Cesena, Italy., Ladell K; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK., Parry HM; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Moss PAH; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Price DA; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.; Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff, UK., Caputo A; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy., Gavioli R; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy., Nicoli F; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy. francesco.nicoli@unife.it.
مؤلفون مشاركون: RIV Study Group
المصدر: Nature aging [Nat Aging] 2024 Aug; Vol. 4 (8), pp. 1121-1136. Date of Electronic Publication: 2024 Jun 25.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Nature Publishing Group US Country of Publication: United States NLM ID: 101773306 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-8465 (Electronic) Linking ISSN: 26628465 NLM ISO Abbreviation: Nat Aging Subsets: MEDLINE
مواضيع طبية MeSH: COVID-19*/immunology , COVID-19*/prevention & control , BNT162 Vaccine*/immunology , SARS-CoV-2*/immunology , 2019-nCoV Vaccine mRNA-1273* , Adaptive Immunity*/immunology , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , Spike Glycoprotein, Coronavirus*/immunology , mRNA Vaccines*/immunology, Humans ; Aged ; Middle Aged ; Adult ; Male ; Female ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Adenovirus Vaccines/immunology ; Adenovirus Vaccines/administration & dosage ; CD8-Positive T-Lymphocytes/immunology ; Age Factors ; ChAdOx1 nCoV-19 ; Aging/immunology ; CD4-Positive T-Lymphocytes/immunology ; Vaccines, Synthetic/immunology ; Vaccines, Synthetic/administration & dosage
-
6دورية أكاديمية
المؤلفون: Chen B; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China., Yang Y; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China., Wang X; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China., Yang W; First Clinical Medical College, Anhui Medical University, Hefei, Anhui 230022, P.R. China., Lu Y; First Clinical Medical College, Anhui Medical University, Hefei, Anhui 230022, P.R. China., Wang D; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China., Zhuo E; Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China., Tang Y; Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China., Su J; Department of Rehabilitation, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China., Tang G; Department of Orthopedics, Lu'an Hospital of Anhui Medical University, Lu'an, Anhui 237008, P.R. China., Shao S; Department of Orthopedics, Lu'an Hospital of Anhui Medical University, Lu'an, Anhui 237008, P.R. China., Gu K; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China.
المصدر: International journal of oncology [Int J Oncol] 2024 Aug; Vol. 65 (2). Date of Electronic Publication: 2024 Jul 12.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Neoplasms*/immunology , Neoplasms*/therapy , Cancer Vaccines*/therapeutic use , Cancer Vaccines*/immunology , mRNA Vaccines* , Vaccine Development*, Humans ; Vaccines, Synthetic/immunology ; Vaccines, Synthetic/therapeutic use ; COVID-19/prevention & control ; COVID-19/immunology ; RNA, Messenger/genetics ; RNA, Messenger/immunology ; Precision Medicine/methods ; Immunotherapy/methods
-
7دورية أكاديمية
المؤلفون: Fazel F; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada., Doost JS; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada., Raj S; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada., Boodhoo N; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada., Karimi K; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada., Sharif S; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada. Electronic address: shayan@uoguelph.ca.
المصدر: Veterinary immunology and immunopathology [Vet Immunol Immunopathol] 2024 Aug; Vol. 274, pp. 110803. Date of Electronic Publication: 2024 Jul 04.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Elsevier Scientific Country of Publication: Netherlands NLM ID: 8002006 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2534 (Electronic) Linking ISSN: 01652427 NLM ISO Abbreviation: Vet Immunol Immunopathol Subsets: MEDLINE
مواضيع طبية MeSH: mRNA Vaccines*, Animals ; Vaccines, Synthetic/immunology ; Viral Vaccines/immunology ; Vaccination/veterinary ; RNA, Messenger/genetics
-
8دورية أكاديمية
المؤلفون: Kim DH; Avian Disease Laboratory, College of Veterinary Medicine, Konkuk University, Seoul, South Korea; KHAV Co., Ltd., 1 Hwayang-dong, Gwangjin-gu, Seoul, Korea., Lee SH; KHAV Co., Ltd., 1 Hwayang-dong, Gwangjin-gu, Seoul, Korea., Kim J; KHAV Co., Ltd., 1 Hwayang-dong, Gwangjin-gu, Seoul, Korea., Lee J; Southeast Poultry Research Laboratory, U.S. National Poultry Research Center, U.S. Department of Agriculture-Agricultural Research Service, 934 College Station Road, Athens, GA 30605, USA., Jeong JH; Avian Disease Laboratory, College of Veterinary Medicine, Konkuk University, Seoul, South Korea; KHAV Co., Ltd., 1 Hwayang-dong, Gwangjin-gu, Seoul, Korea., Kim JY; KHAV Co., Ltd., 1 Hwayang-dong, Gwangjin-gu, Seoul, Korea., Song SU; Avian Disease Laboratory, College of Veterinary Medicine, Konkuk University, Seoul, South Korea., Lee H; KHAV Co., Ltd., 1 Hwayang-dong, Gwangjin-gu, Seoul, Korea., Cho AY; Avian Disease Laboratory, College of Veterinary Medicine, Konkuk University, Seoul, South Korea., Hyeon JY; Avian Disease Laboratory, College of Veterinary Medicine, Konkuk University, Seoul, South Korea., Youk S; Department of Microbiology, College of Medicine, Chungbuk National University, Cheongju, South Korea. Electronic address: sungsu.youk@chungbuk.ac.kr., Song CS; Avian Disease Laboratory, College of Veterinary Medicine, Konkuk University, Seoul, South Korea; KHAV Co., Ltd., 1 Hwayang-dong, Gwangjin-gu, Seoul, Korea. Electronic address: songcs@konkuk.ac.kr.
المصدر: Vaccine [Vaccine] 2024 Jul 11; Vol. 42 (18), pp. 3756-3767. Date of Electronic Publication: 2024 May 09.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
مواضيع طبية MeSH: Chickens*/immunology , Influenza in Birds*/prevention & control , Influenza in Birds*/immunology , Newcastle disease virus*/immunology , Newcastle disease virus*/genetics , Influenza A Virus, H5N1 Subtype*/immunology , Influenza A Virus, H5N1 Subtype*/genetics , Influenza A Virus, H5N1 Subtype*/pathogenicity , Ducks*/virology , Ducks*/immunology , Vaccines, Inactivated*/immunology , Vaccines, Inactivated*/administration & dosage , Virus Shedding* , Vaccines, Synthetic*/immunology , Vaccines, Synthetic*/administration & dosage , Vaccines, Synthetic*/genetics , Antibodies, Viral*/immunology , Antibodies, Viral*/blood , Hemagglutinin Glycoproteins, Influenza Virus*/immunology , Hemagglutinin Glycoproteins, Influenza Virus*/genetics, Animals ; Influenza Vaccines/immunology ; Influenza Vaccines/administration & dosage ; Influenza Vaccines/genetics ; Specific Pathogen-Free Organisms ; Vaccines, Attenuated/immunology ; Vaccines, Attenuated/administration & dosage ; Vaccines, Attenuated/genetics ; Poultry Diseases/prevention & control ; Poultry Diseases/virology ; Poultry Diseases/immunology ; Newcastle Disease/prevention & control ; Newcastle Disease/immunology ; Viral Vaccines/immunology ; Viral Vaccines/administration & dosage ; Viral Vaccines/genetics
-
9دورية أكاديمية
المؤلفون: Shaw CA; Infectious Disease, Research and Development, Moderna, Inc, Cambridge, Massachusetts., Essink B; Velocity Clinical Research, Omaha, Nebraska., Harper C; Velocity Clinical Research, Omaha, Nebraska., Mithani R; Infectious Disease, Research and Development, Moderna, Inc, Cambridge, Massachusetts., Kapoor A; Infectious Disease, Research and Development, Moderna, Inc, Cambridge, Massachusetts., Dhar R; Infectious Disease, Research and Development, Moderna, Inc, Cambridge, Massachusetts., Wilson L; Infectious Disease, Research and Development, Moderna, Inc, Cambridge, Massachusetts., Guo R; Infectious Disease, Research and Development, Moderna, Inc, Cambridge, Massachusetts., Panozzo CA; Infectious Disease, Research and Development, Moderna, Inc, Cambridge, Massachusetts., Wilson E; Infectious Disease, Research and Development, Moderna, Inc, Cambridge, Massachusetts., Simorellis AK; Infectious Disease, Research and Development, Moderna, Inc, Cambridge, Massachusetts., Reuter C; Infectious Disease, Research and Development, Moderna, Inc, Cambridge, Massachusetts., Stoszek SK; Infectious Disease, Research and Development, Moderna, Inc, Cambridge, Massachusetts., Chen GL; Infectious Disease, Research and Development, Moderna, Inc, Cambridge, Massachusetts., Das R; Infectious Disease, Research and Development, Moderna, Inc, Cambridge, Massachusetts., Goswami J; Infectious Disease, Research and Development, Moderna, Inc, Cambridge, Massachusetts.
المصدر: The Journal of infectious diseases [J Infect Dis] 2024 Sep 23; Vol. 230 (3), pp. e647-e656.
نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
مواضيع طبية MeSH: Respiratory Syncytial Virus Vaccines*/immunology , Respiratory Syncytial Virus Vaccines*/adverse effects , Respiratory Syncytial Virus Vaccines*/administration & dosage , Respiratory Syncytial Virus Infections*/prevention & control , Respiratory Syncytial Virus Infections*/immunology , Immunization, Secondary* , Antibodies, Viral*/blood, Humans ; Male ; Aged ; Female ; Respiratory Syncytial Virus, Human/immunology ; Respiratory Syncytial Virus, Human/genetics ; Immunogenicity, Vaccine ; RNA, Messenger/immunology ; RNA, Messenger/genetics ; Antibodies, Neutralizing/blood ; mRNA Vaccines ; Vaccines, Synthetic/immunology ; Vaccines, Synthetic/adverse effects ; Vaccines, Synthetic/administration & dosage
-
10دورية أكاديمية
المؤلفون: Pather S; BioNTech SE, Mainz, Germany., Charpentier N; BioNTech SE, Mainz, Germany., van den Ouweland F; BioNTech SE, Mainz, Germany., Rizzi R; BioNTech SE, Mainz, Germany., Finlayson A; BioNTech SE, Mainz, Germany., Salisch N; BioNTech SE, Mainz, Germany., Muik A; BioNTech SE, Mainz, Germany., Lindemann C; BioNTech SE, Mainz, Germany., Khanim R; BioNTech SE, Mainz, Germany., Abduljawad S; BioNTech SE, Mainz, Germany., Smith ER; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA. Electronic address: bc-coordinator@taskforce.org., Gurwith M; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA., Chen RT; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA.
المصدر: Vaccine [Vaccine] 2024 Sep 17; Vol. 42 (22), pp. 126165. Date of Electronic Publication: 2024 Aug 27.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
مواضيع طبية MeSH: COVID-19 Vaccines*/adverse effects , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , COVID-19*/prevention & control , BNT162 Vaccine*/immunology , SARS-CoV-2*/immunology , SARS-CoV-2*/genetics , mRNA Vaccines*, Humans ; Risk Assessment ; Vaccines, Synthetic/adverse effects ; Vaccines, Synthetic/immunology ; Immunogenicity, Vaccine
SCR Organism: SARS-CoV-2 variants